Descripción del proyecto
Nuevo método de detección del melanoma
La incidencia de cáncer de piel ha aumentado durante las últimas décadas. Cada año se diagnostican en torno a tres millones de casos de cáncer de piel. El melanoma maligno es el tipo más peligroso de tumor cutáneo. El diagnóstico precoz se asocia con una mejora de la calidad de vida en estos pacientes, pero las metodologías actuales resultan poco fiables y no se utilizan con la frecuencia que sería necesaria. El proyecto financiado con fondos europeos MERWIS se centra en aumentar la frecuencia de las exploraciones. Esto significa que realiza un seguimiento de la evolución (cambios) de cada uno de los lunares supervisados con una frecuencia alta o muy alta. Dado que la mayor parte de los signos clínicos del melanoma son visibles, MERWIS utiliza una cabina de cartografiado corporal, una aplicación móvil y un «software» de análisis de datos cualitativos asistido por ordenador para detectar todos los cambios visibles del melanoma.
Objetivo
However, there are several tools and solutions for aiding the melanoma detection (variable dermatoscopes, full-body mapping tools and Applications), they were not able to achieve breakthrough in the early diagnosis phase. It comes from the wrong methodologies. There are two types of available tools: 1) diagnostic tools, whit the aim of diagnosing skin-cancer without human intervention, and 2) medical equipment, which help the work of dermatologist during the examination in a doctor’s office. The problem with first methodology (artificial based skin-cancer diagnosis) is that these do not work reliable or do not work at all. The main problem of the second methodology is the very rare examination frequency. An average health conscious European adult visits skin-cancer screening in every 3-7 years.
In contrast with these, MERWIS offers a solution that focuses on increasing the examination frequency, where the system does not need to establish a full diagnosis. MERWIS only looks for evolution (change) of every single monitored mole, but with high or very high frequency.
The validated and demonstrated MERWIS prototype is based on the fact that most clinical signs of melanoma are all visible. Through using the combination of a special body-mapping cabin, a mobile application based “self dermoscopy”, and a computer assisted qualitative data analysis software we can detect all the visible changes of melanoma ABCDE. Furthermore our system uses a custom made distributed ledger technology-based network cloud solution. Based on this framework it is possible to build the MERWIS decentralized database on a maximum security level and ensure scalability.
The aim of this Phase 1 project is to carry out an extended feasibility study consisting of market assessment, business model validation, risk and IP strategy assessment, up-date and advancement of the business plan, and international pilot location selection to support the global commercialisation of our technology.
Ámbito científico
- natural sciencescomputer and information sciencesdata science
- natural sciencescomputer and information sciencessoftware
- natural sciencescomputer and information sciencesdatabases
- medical and health sciencesclinical medicineoncologyskin cancermelanoma
- social scienceseconomics and businessbusiness and managementbusiness models
Programa(s)
Convocatoria de propuestas
Consulte otros proyectos de esta convocatoriaConvocatoria de subcontratación
H2020-SMEInst-2018-2020-1
Régimen de financiación
SME-1 - SME instrument phase 1Coordinador
1183 BUDAPEST
Hungría
Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.